May contain inaccuracies · Check primary sources · Not medical advice · Not for human or animal use

Non-peptide

RU-58841

Also known as

RU58841 · PSK-3841 · PSK3841 · RU 58841 · topical RU · 5% RU

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

IdentityAn experimental topical androgen-receptor blocker discussed for pattern hair loss, especially when finasteride seems inadequate or unwanted.
Different mechanismRU blocks receptors rather than reducing DHT production like finasteride or dutasteride. Scalp application does not establish that it stays out of blood.
Notes

RU-58841 is an experimental topical androgen blocker discussed for pattern hair loss. People seek less shedding or extra regrowth when finasteride is inadequate or unwanted. Accounts include years of claimed maintenance, no improvement, and symptoms that prompted stopping; putting it on the scalp does not establish that it stays there.

A receptor blocker, rather than a DHT-lowering drug. RU is a nonsteroidal antiandrogen, not a peptide. The idea is to occupy the androgen receptor, where hormones send signals to cells. Finasteride and dutasteride instead reduce production of DHT, an androgen involved in follicle shrinkage. Battmann et al. — RU 58841, a new specific topical antiandrogen (1994) (Animal context · Accessed 2026-09-30) · Why is RU58841 effective when the half life is only 1 hour? (Secondhand community claim · Accessed 2026-09-30)

One small human study found systemic exposure. In six men, one 30 mg scalp application entered blood, peaking within 12 hours and falling near baseline by 36. Only one had low findings after 120 hours, through the final 168-hour sample; urine metabolites lasted up to 213 hours. The bottle labeled 50 mg/mL measured 30. Unchanged single-dose steroid markers prove neither chronic safety nor a human half-life. Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans (Official context · Accessed 2026-09-30)

Source context — Battmann et al. — RU 58841, a new specific topical antiandrogen (1994): Abstract only, not full paper; animal receptor and local-action findings do not prove human selectivity or safety. Europe PMC abstract used after PubMed access became inconsistent.

Source context — Why is RU58841 effective when the half life is only 1 hour?: No topical human clearance measurement supplied. Underlying formal origin is Cousty-Berlin 1994 rat intravenous work, independently checked through abstract. Community metabolite percentage/20-hour statements are not validated as human values or converted into schedules.

Source context — Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans: Small single-dose analytical study, not hair-efficacy, cardiovascular or long-term-safety trial. Text says all six had blood detection but after 120 hours only one retained low findings: final 168-hour detection must not be assigned to everyone. PMC and Wiley are the same source origin, not independent studies.

What people notice

Less shedding and density gainsSome long-term users claim regrowth or maintenance, usually alongside finasteride or minoxidil; one says RU alone would not stop their loss.
No result or fading benefitOne RU-only user reported no useful effect after nine months; another described initial regrowth followed by fading benefit after five years.
Interrupted useLong-term users describe shedding during breaks and improvement after restarting; these histories do not measure one application's benefit.
Notes

Less shedding and better density. A five-year user describes regrowth and maintenance after finasteride alone disappointed them. Another six-to-seven-year user reports extra regrowth alongside finasteride and minoxidil, yet says RU alone would not stop their loss. These are personal accounts, not evidence that RU replaces either treatment. RU58841 longterm use and expectations (Personal report · Accessed 2026-09-30) · RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30)

No benefit can be the reason to quit. A HairLossTalk user reports nine months of RU alone, no noticed side effects and no useful effect. Another reports initial regrowth followed by fading benefit after five years; later maintenance involved finasteride and clascoterone too. Higher amounts or more treatments did not resolve attribution. Ru58841 Before/after Pics And Experiences (Community discussion · Accessed 2026-09-30)

No reliable single-application hair-benefit duration. Long-term users describe ongoing application. The five-year user reports severe shedding during a May-to-update interruption and improvement after restarting; the six-to-seven-year user describes shedding after more than ten days off. Neither account measures receptor blocking or a universal washout period. RU58841 longterm use and expectations (Personal report · Accessed 2026-09-30) · RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30)

Source context — RU58841 longterm use and expectations: Concentration, volume and concurrent treatments not fully specified. Product, photos and hair changes not independently verified. Symptom-free use does not establish chronic safety. Relative publication date retained as unknown.

Source context — RU58841 users — long-term experience and side effects?: Unverified products and subjective symptoms. Same-author replies not separate accounts. Later self-treatment, concurrent fin/min and concentration changes confound attribution. Allegations explaining trial abandonment and comparative safety not adopted.

Source context — Ru58841 Before/after Pics And Experiences: Photos not independently reviewed; doses, products and outcomes unverified. Quoted repetitions are the same reports. Sourcing endorsements and death rumors not accepted. Article-derived prose for this non-Reddit origin is under 75 words.

Doses people talk about

5% scalp-liquid bandA claimed 50 mg/mL at 0.5–1 mL once daily means nominally 25–50 mg on the scalp, not an absorbed dose; bottle strength is unverified in these accounts.
Smaller-volume account0.25 mL of 5% daily, nominally 12.5 mg, with stemoxydine in one account. Separate notes discuss 2–3% solutions.
Different higher-amount account75 mg/day in 2 mL in another thread; it is a separate formulation and exposure, not a safe ceiling.
Notes

5% means a claimed 50 mg/mL. The existing community band is 0.5–1 mL once daily, nominally 25–50 mg on the scalp, not an absorbed dose. The inspected stacked poster reports 1 mL of 5% daily. Bottle strength is unverified in these accounts. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30)

Lower-strength and smaller-volume experiments differ. Existing notes describe 2–3% solutions. A separate commenter reports 0.25 mL of 5% daily, nominally 12.5 mg, with stemoxydine. Another thread's author reports 75 mg/day in 2 mL. These are separate formulations and amounts, not one interchangeable range or a safe ceiling. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30) · Why is RU58841 effective when the half life is only 1 hour? (Secondhand community claim · Accessed 2026-09-30)

Source context — RU58841 is great, super fast acting!: Uncontrolled anonymous reports, unverified liquids and strong co-treatment confounding. OP's time descriptions vary between month-and-a-half and about two months. Relative post dates not converted. Recovery and acute report are one person.

Source context — Why is RU58841 effective when the half life is only 1 hour?: No topical human clearance measurement supplied. Underlying formal origin is Cousty-Berlin 1994 rat intravenous work, independently checked through abstract. Community metabolite percentage/20-hour statements are not validated as human values or converted into schedules.

Half-life, onset & duration

Felt onsetOne stemoxydine co-user claimed less shedding after a week and thicker hair at 3–4 weeks. Other accounts use 3–6-month photos.
Felt durationNo reliable single-application hair-benefit window. Shedding after interruptions and symptoms persisting after stopping do not measure drug clearance.
Half-lifeNo topical human value established here. The circulated one-hour parent and 20-hour metabolite figures derive from rat IV work.
Blood peakWithin 12 hours after one 30 mg scalp application in six men, with blood levels near baseline by 36 hours; this is not a half-life or chronic-safety result.
Notes

Less shedding after a week is one report; hair-photo follow-ups span months. The stemoxydine co-user claims less loss after one week and thicker hair at 3–4 weeks. Replies dispute rapid regrowth attribution. Existing notes describe shedding during weeks 2–8 and photo comparisons at 3–6 months; other users see nothing. These are different outcomes, not a dependable onset window. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30)

No reliable single-application hair-benefit duration. Long-term users describe ongoing application. The five-year user reports severe shedding during a May-to-update interruption and improvement after restarting; the six-to-seven-year user describes shedding after more than ten days off. Neither account measures receptor blocking or a universal washout period. RU58841 longterm use and expectations (Personal report · Accessed 2026-09-30) · RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30)

Symptoms can outlast the last application. One commenter felt normal 3–4 days after a single use and an ER visit. A different six-month user reports incomplete mood and libido recovery four years later. These histories neither measure drug persistence nor establish what caused the symptoms. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30) · RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30)

One hour for RU and 20 hours for a metabolite circulate online. A Reddit reply repeats those figures for RU and RU56279, a breakdown product. The underlying clearance work was in rats given an intravenous dose, not people applying scalp liquid. These numbers do not establish a topical human half-life. Why is RU58841 effective when the half life is only 1 hour? (Secondhand community claim · Accessed 2026-09-30)

Another poster reads the rat paper as about 6 hours and 24 hours. That is their interpretation for RU and its metabolites; the paper's abstract actually describes parent clearance around one hour. Competing readings of animal work cannot settle human timing or justify an application schedule. Methods Of Staying Safe On Ru58841 - My 2 Cents (Secondhand community claim · Accessed 2026-09-30)

One small human study found systemic exposure. In six men, one 30 mg scalp application entered blood, peaking within 12 hours and falling near baseline by 36. Only one had low findings after 120 hours, through the final 168-hour sample; urine metabolites lasted up to 213 hours. The bottle labeled 50 mg/mL measured 30. Unchanged single-dose steroid markers prove neither chronic safety nor a human half-life. Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans (Official context · Accessed 2026-09-30)

Source context — RU58841 is great, super fast acting!: Uncontrolled anonymous reports, unverified liquids and strong co-treatment confounding. OP's time descriptions vary between month-and-a-half and about two months. Relative post dates not converted. Recovery and acute report are one person.

Source context — RU58841 longterm use and expectations: Concentration, volume and concurrent treatments not fully specified. Product, photos and hair changes not independently verified. Symptom-free use does not establish chronic safety. Relative publication date retained as unknown.

Source context — RU58841 users — long-term experience and side effects?: Unverified products and subjective symptoms. Same-author replies not separate accounts. Later self-treatment, concurrent fin/min and concentration changes confound attribution. Allegations explaining trial abandonment and comparative safety not adopted.

Source context — Why is RU58841 effective when the half life is only 1 hour?: No topical human clearance measurement supplied. Underlying formal origin is Cousty-Berlin 1994 rat intravenous work, independently checked through abstract. Community metabolite percentage/20-hour statements are not validated as human values or converted into schedules.

Source context — Methods Of Staying Safe On Ru58841 - My 2 Cents: User-created analysis with linked personal training blog, not original measurements. Reads rat clearance differently from the primary abstract. Safety assurances, endocrine timing, grapefruit modification, metabolite safety and suggested breaks are unsupported and not adopted as guidance.

Source context — Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans: Small single-dose analytical study, not hair-efficacy, cardiovascular or long-term-safety trial. Text says all six had blood detection but after 120 hours only one retained low findings: final 168-hour detection must not be assigned to everyone. PMC and Wiley are the same source origin, not independent studies.

Cycles people discuss

Maintenance useDaily 3–6-month photo trials and years of continued application appear, with some users reporting shedding during interruptions.
Deliberate breaksOne stemoxydine co-user reports 2–3 months on/1–2 off hoping to avoid buildup; that protection and a shared break length are unproven.
Notes

Maintenance use and deliberate breaks both appear. Existing notes describe daily 3–6-month photo trials, followed by continuing or abandoning it. The stemoxydine co-user reports 2–3 months on and 1–2 months off, hoping to avoid buildup. Others describe years of use and shedding interruptions. That hoped-for protection is unproven; no shared cycle or break length is established. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30) · RU58841 longterm use and expectations (Personal report · Accessed 2026-09-30)

Source context — RU58841 is great, super fast acting!: Uncontrolled anonymous reports, unverified liquids and strong co-treatment confounding. OP's time descriptions vary between month-and-a-half and about two months. Relative post dates not converted. Recovery and acute report are one person.

Source context — RU58841 longterm use and expectations: Concentration, volume and concurrent treatments not fully specified. Product, photos and hair changes not independently verified. Symptom-free use does not establish chronic safety. Relative publication date retained as unknown.

Stacks

Minoxidil and fin/dutMinoxidil plus finasteride or dutasteride is prominent in saved stacks, including oral-minoxidil combinations; gains and symptoms cannot be assigned to RU alone.
StemoxydineAccompanied the 0.25 mL daily account and its early shedding/density claims.
MicroneedlingAppears in hair-stack culture; needled or broken skin adds irritation and is different from intact-scalp application.
Notes

Minoxidil: It appears in several accounts, adding another treatment and sometimes another irritating liquid vehicle. Neither benefits nor irritation can automatically be assigned to RU. [community]

Finasteride or dutasteride: These reduce DHT production while RU targets receptors. The mechanistic distinction does not establish the benefit or safety of combining them. [community]

Combined hair treatments: Saved 2026 notes include finasteride or dutasteride and oral minoxidil alongside RU, sometimes during performance-drug use. These multiple exposures complicate both hair-response and chest-symptom attribution. [community]

An additional treatment in a complicated combination. A short-term success poster also used topical finasteride, minoxidil and dutasteride, injectable GHK-Cu and testosterone replacement. They acknowledged they could not tell which treatment helped. The appeal of scalp receptor blocking does not establish freedom from whole-body effects. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30)

Lower-strength and smaller-volume experiments differ. Existing notes describe 2–3% solutions. A separate commenter reports 0.25 mL of 5% daily, nominally 12.5 mg, with stemoxydine. Another thread's author reports 75 mg/day in 2 mL. These are separate formulations and amounts, not one interchangeable range or a safe ceiling. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30) · Why is RU58841 effective when the half life is only 1 hour? (Secondhand community claim · Accessed 2026-09-30)

Less shedding after a week is one report; hair-photo follow-ups span months. The stemoxydine co-user claims less loss after one week and thicker hair at 3–4 weeks. Replies dispute rapid regrowth attribution. Existing notes describe shedding during weeks 2–8 and photo comparisons at 3–6 months; other users see nothing. These are different outcomes, not a dependable onset window. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30)

Microneedling: It appears in some hair routines. Irritated or needled skin is a different exposure context, not evidence of a better or safer combination. [community]

Sting, dryness and itch are different from a hair-loss shed. Alcohol and propylene glycol feature in irritation reports, including dermatitis. Minoxidil liquids can add another irritating vehicle. Existing notes also flag microneedling or broken skin and accidental transfer to partners. These conditions should not be treated as equivalent to ordinary intact-scalp use.

Source context — RU58841 is great, super fast acting!: Uncontrolled anonymous reports, unverified liquids and strong co-treatment confounding. OP's time descriptions vary between month-and-a-half and about two months. Relative post dates not converted. Recovery and acute report are one person.

Source context — Why is RU58841 effective when the half life is only 1 hour?: No topical human clearance measurement supplied. Underlying formal origin is Cousty-Berlin 1994 rat intravenous work, independently checked through abstract. Community metabolite percentage/20-hour statements are not validated as human values or converted into schedules.

Watch for

Scalp irritation and transferAlcohol/propylene-glycol vehicles can sting, dry or irritate skin; other liquids can add irritation. The record also flags accidental transfer to partners.
Chest, mood and sexual symptomsReports include palpitations, breathlessness, low mood and weaker erections. Frequency and cause are unknown; chest symptoms deserve medical attention.
Lower amounts did not settle symptomsOne user initially felt better after reducing 40–50 mg to 20 mg, but later reported persistent symptoms, no hair improvement and stopping.
Bottle contentsIn one small human study, a bottle labeled 50 mg/mL measured 30 mg/mL. Labels and appearance do not verify strength or establish long-term safety.
Notes

Sting, dryness and itch are different from a hair-loss shed. Alcohol and propylene glycol feature in irritation reports, including dermatitis. Minoxidil liquids can add another irritating vehicle. Existing notes also flag microneedling or broken skin and accidental transfer to partners. These conditions should not be treated as equivalent to ordinary intact-scalp use.

Chest symptoms, mood changes and sexual complaints deserve attention. Reports include palpitations, breathlessness, low mood and weaker erections. Their frequency and cause are unknown. Normal tests after one ER visit do not make chest symptoms safe to push through. Long-term safety and interactions with stacked treatments remain unresolved. RU58841 is great, super fast acting! (Community discussion · Accessed 2026-09-30) · RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30) · For long term ru58841 users who experienced side effects, did they go away after some time? (Community discussion · Accessed 2026-09-30)

Early relief did not settle one user's adverse timeline. A finasteride co-user first reported chest tightness and breathlessness at 40–50 mg per application, almost daily. They later described relief after lowering to 20 mg, briefly every other day then daily. Their final edit says symptoms persisted, hair did not improve and they stopped after several months. For long term ru58841 users who experienced side effects, did they go away after some time? (Community discussion · Accessed 2026-09-30)

One small human study found systemic exposure. In six men, one 30 mg scalp application entered blood, peaking within 12 hours and falling near baseline by 36. Only one had low findings after 120 hours, through the final 168-hour sample; urine metabolites lasted up to 213 hours. The bottle labeled 50 mg/mL measured 30. Unchanged single-dose steroid markers prove neither chronic safety nor a human half-life. Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans (Official context · Accessed 2026-09-30)

The liquid and the alternatives matter. People debate solution yellowing, refrigeration and whether potency changed; appearance cannot verify strength. Evening versus morning reflects convenience, not proven superiority. Pyrilutamide comparisons often concern switching because of reactions or identity worries. Claims that either topical is automatically safer, or that an acne approval establishes hair efficacy, go beyond these accounts. RU58841 users — long-term experience and side effects? (Community discussion · Accessed 2026-09-30)

Source context — RU58841 is great, super fast acting!: Uncontrolled anonymous reports, unverified liquids and strong co-treatment confounding. OP's time descriptions vary between month-and-a-half and about two months. Relative post dates not converted. Recovery and acute report are one person.

Source context — RU58841 users — long-term experience and side effects?: Unverified products and subjective symptoms. Same-author replies not separate accounts. Later self-treatment, concurrent fin/min and concentration changes confound attribution. Allegations explaining trial abandonment and comparative safety not adopted.

Source context — For long term ru58841 users who experienced side effects, did they go away after some time?: Final edit supersedes the reassuring interim RU update. Finasteride's separate recovery history must not be assigned to RU. Lowering amount is a report, not a harm-reduction recommendation.

Source context — Okutan et al. — Investigation Into the Metabolism and Elimination Behavior of RU 58841, and Its Influence on the Steroid Profile in Humans: Small single-dose analytical study, not hair-efficacy, cardiovascular or long-term-safety trial. Text says all six had blood detection but after 120 hours only one retained low findings: final 168-hour detection must not be assigned to everyone. PMC and Wiley are the same source origin, not independent studies.

Full notes

RU-58841 is an experimental topical androgen blocker discussed for pattern hair loss. People seek less shedding or extra regrowth when finasteride is inadequate or unwanted. Accounts include years of claimed maintenance, no improvement, and symptoms that prompted stopping; putting it on the scalp does not establish that it stays there.

What RU-58841 actually is

  • A receptor blocker, rather than a DHT-lowering drug. RU is a nonsteroidal antiandrogen, not a peptide. The idea is to occupy the androgen receptor, where hormones send signals to cells. Finasteride and dutasteride instead reduce production of DHT, an androgen involved in follicle shrinkage. Animal context Reddit r/tressless
  • Scalp liquid, with uncertain product identity. Community products are powders made into liquids or premixed solutions, often with alcohol and propylene glycol, a solvent. PSK-3841 is a development code, not proof a bottle matches trial material. Pyrilutamide and clascoterone are different compounds; RU has no marketed hair-drug label. Community

What people hope to gain

  • Less shedding and better density. A five-year user describes regrowth and maintenance after finasteride alone disappointed them. Another six-to-seven-year user reports extra regrowth alongside finasteride and minoxidil, yet says RU alone would not stop their loss. These are personal accounts, not evidence that RU replaces either treatment. Personal report Reddit r/HairlossResearch
  • An additional treatment in a complicated combination. A short-term success poster also used topical finasteride, minoxidil and dutasteride, injectable GHK-Cu and testosterone replacement. They acknowledged they could not tell which treatment helped. The appeal of scalp receptor blocking does not establish freedom from whole-body effects. Reddit r/tressless Community

Doses people discuss

Reported topical amounts, not a regimen. Concentration describes the liquid; volume determines the labeled amount applied.

  • 5% means a claimed 50 mg/mL. The existing community band is 0.5–1 mL once daily, nominally 25–50 mg on the scalp, not an absorbed dose. The inspected stacked poster reports 1 mL of 5% daily. Bottle strength is unverified in these accounts. Community Reddit r/tressless
  • Lower-strength and smaller-volume experiments differ. Existing notes describe 2–3% solutions. A separate commenter reports 0.25 mL of 5% daily, nominally 12.5 mg, with stemoxydine. Another thread's author reports 75 mg/day in 2 mL. These are separate formulations and amounts, not one interchangeable range or a safe ceiling. Community Reddit r/tressless Reddit r/tressless

Half-life

  • One hour for RU and 20 hours for a metabolite circulate online. A Reddit reply repeats those figures for RU and RU56279, a breakdown product. The underlying clearance work was in rats given an intravenous dose, not people applying scalp liquid. These numbers do not establish a topical human half-life. Reddit r/tressless
  • Another poster reads the rat paper as about 6 hours and 24 hours. That is their interpretation for RU and its metabolites; the paper's abstract actually describes parent clearance around one hour. Competing readings of animal work cannot settle human timing or justify an application schedule. Reddit r/tressless

Onset: when people notice something

  • Less shedding after a week is one report; hair-photo follow-ups span months. The stemoxydine co-user claims less loss after one week and thicker hair at 3–4 weeks. Replies dispute rapid regrowth attribution. Existing notes describe shedding during weeks 2–8 and photo comparisons at 3–6 months; other users see nothing. These are different outcomes, not a dependable onset window. Reddit r/tressless Community

Duration: after an application or stopping

  • No reliable single-application hair-benefit duration. Long-term users describe ongoing application. The five-year user reports severe shedding during a May-to-update interruption and improvement after restarting; the six-to-seven-year user describes shedding after more than ten days off. Neither account measures receptor blocking or a universal washout period. Personal report Reddit r/HairlossResearch
  • Symptoms can outlast the last application. One commenter felt normal 3–4 days after a single use and an ER visit. A different six-month user reports incomplete mood and libido recovery four years later. These histories neither measure drug persistence nor establish what caused the symptoms. Reddit r/tressless Reddit r/HairlossResearch

Cycles and time off

  • Maintenance use and deliberate breaks both appear. Existing notes describe daily 3–6-month photo trials, followed by continuing or abandoning it. The stemoxydine co-user reports 2–3 months on and 1–2 months off, hoping to avoid buildup. Others describe years of use and shedding interruptions. That hoped-for protection is unproven; no shared cycle or break length is established. Community Reddit r/tressless Personal report

Good to know

  • Sting, dryness and itch are different from a hair-loss shed. Alcohol and propylene glycol feature in irritation reports, including dermatitis. Minoxidil liquids can add another irritating vehicle. Existing notes also flag microneedling or broken skin and accidental transfer to partners. These conditions should not be treated as equivalent to ordinary intact-scalp use. Community
  • Chest symptoms, mood changes and sexual complaints deserve attention. Reports include palpitations, breathlessness, low mood and weaker erections. Their frequency and cause are unknown. Normal tests after one ER visit do not make chest symptoms safe to push through. Long-term safety and interactions with stacked treatments remain unresolved. Reddit r/tressless Reddit r/HairlossResearch Reddit r/tressless

What supporting research can clarify

  • One small human study found systemic exposure. In six men, one 30 mg scalp application entered blood, peaking within 12 hours and falling near baseline by 36. Only one had low findings after 120 hours, through the final 168-hour sample; urine metabolites lasted up to 213 hours. The bottle labeled 50 mg/mL measured 30. Unchanged single-dose steroid markers prove neither chronic safety nor a human half-life. Official context
  • Animal hair results are supporting context. Human scalp grafts on mice showed more repeat hair cycles and faster growth with 1% in ethanol five days weekly. A macaque study reported thicker, denser hair. Neither establishes benefit or safe amounts for human users. Animal context Animal context

What the accounts add

  • No benefit can be the reason to quit. A HairLossTalk user reports nine months of RU alone, no noticed side effects and no useful effect. Another reports initial regrowth followed by fading benefit after five years; later maintenance involved finasteride and clascoterone too. Higher amounts or more treatments did not resolve attribution. HairLossTalk
  • Early relief did not settle one user's adverse timeline. A finasteride co-user first reported chest tightness and breathlessness at 40–50 mg per application, almost daily. They later described relief after lowering to 20 mg, briefly every other day then daily. Their final edit says symptoms persisted, hair did not improve and they stopped after several months. Reddit r/tressless
  • One ER story includes its recovery update. After one 0.5 mL application of 5%, a commenter describes lightheadedness that day, then chest pain and palpitations, prompting an ER visit. They report normal ECG, heart ultrasound and blood tests, then feeling normal 3–4 days later. Replies calling it anxiety did not establish a diagnosis. Reddit r/tressless
  • A lower percentage did not prevent another reported reaction. One account describes chest pain while running with premixed 5%, breathlessness and cough with homemade 2.5%, then disabling fatigue after 0.5 mL the next morning. Throat and chest symptoms quieted after stopping. Product identity and causation were not verified. Community
  • Long-term accounts disagree, including within the same story. The six-to-seven-year user claims no cardiovascular issues, but also describes early palpitation-like sensations and more problems above 5%. Another stopped after six months: urinary symptoms resolved, while mood and libido remained below baseline years later; later D-phenylalanine use complicates their recovery account. A separate commenter reports perceived facial-fat loss with incomplete recovery. Reddit r/HairlossResearch
  • The liquid and the alternatives matter. People debate solution yellowing, refrigeration and whether potency changed; appearance cannot verify strength. Evening versus morning reflects convenience, not proven superiority. Pyrilutamide comparisons often concern switching because of reactions or identity worries. Claims that either topical is automatically safer, or that an acne approval establishes hair efficacy, go beyond these accounts. Community Reddit r/HairlossResearch

Open in the directory ↗All STUDresearch topics →